Podcasts

“We cannot give if our cup is empty,” says Diana Londoño, MD.

“I thought identity theft was simple. You fix this 1 little thing. Today, what physicians and health care professionals need to be on the lookout for is [that] it's much different,” says Mark A. Moyad, MD, MPH, on the latest Speaking of Urology podcast episode.

“It doesn't need to be surgery or radiation. Setting that stage, really focusing on those conversations, using the appropriate tools that we've grasped from behavioral psychologists that are being used by negotiation specialists, are critical in medicine,” says Behfar Ehdaie, MD, MPH.

It's the hidden gem in medicine,” says Efe Chantal Ghanney Simons, MD.

"Many people do not examine patients who come in with urinary tract infections or overactive bladder symptoms, and it’s a mistake,” says Rachel S. Rubin, MD.

“We find that consuming more healthy, plant-based foods is associated with a lower risk of aggressive and lethal prostate cancer, and has many other health benefits, too,” says Stacy Loeb, MD, PhD, MSc.

“The root cause, I think, of most of the problems is a severe erosion of the patient-physician relationship,” William Lynes, MD.

“I think that for the urologist, a lot of what we do in practice is very much appropriate for telemedicine,” says Kara L. Watts, MD.

“It's not a replacement for clinical judgment, obviously. But at the end of the day, the idea is that it shows you what your next steps are based on what the American Urological Association and [Society of Urologic Oncology] guidelines are for non-muscle invasive bladder cancer,” Chad R. Ritch, MD, MBA, FACS.

“All of human health is inextricably linked with environmental health,” says Stacy Loeb, MD, PhD, MSc.

“[Promoting anti-microbial resistance is] really the only stigma and it's not the fault of the patients with recurrent urinary tract infection…most of us in the medical profession realize that this stigma is more the result of our only treatment we have for this condition,” says J. Curtis Nickel, MD, FRCSC.

“I wouldn't be surprised if we have spotty distribution areas of concern for the next several years,” says Sam S. Chang MD, MBA, on the latest episode of the UT podcast Speaking of Urology.

“That's certainly the most significant stigma, the stigma that you're not quite the man that you want to be or what you perceive your partner wants you to be,” says Arthur L. Burnett, MD, MBA, FACS.

“As health care professionals, we've got…an incredibly important role and responsibility with regards to increasing awareness and education, and then really trying to address the barriers and bring down the barriers,” says Jai Seth, MD.

“Our study strongly suggests that telemedicine can become the mainstay of treatment within FPMRS even after the COVID-19 pandemic has ended,” says Christina Shin, BA.

“Opioids are opioids…they can lead to long-term usage regardless of their FDA class. We really need to be good stewards for our patients,” says Sarah F. Faris, MD.

“We need to do a better job sampling the prostate,” says Matthew J. Allaway, MD.

“We're not saying a blanket stop for all patients, but I think we do need to be taking each patient as an individual in terms of their backgrounds,” says Jai Seth, MD.

“You have tradeoffs with every device that you use,” says Amy E. Krambeck, MD.

“A lot of clinicians are seeing transgender and gender-diverse people in their practice, whether it’s urology, whether it’s primary care, whether it’s other subspecialties…[They should have an understanding] that transgender and gender-diverse people are at a higher risk of a multitude of mental health diagnoses,” says David A. Klein, MD, MPH.

“Same-day discharge is safe and feasible across a broad spectrum of FPMRS cases,” says Jacqueline Zillioux, MD.

“Their opinions do need to be credible and be honest, but there is some component of being able to walk a line between providing a candid, unbiased opinion, and knowing that you are retained to represent a specific side in that case,” says Kenton H. Steele, Esq.

“I think it's the responsibility of the physician to really take on educating and counseling and setting clear expectations and that way, when complications do arise, patients are better equipped, and they have a more favorable outcome,” says Ariana Matz, MD.

“I think one of the most surprising things to us as we started to look at the data is that we had a very low rate of no shows amongst telemedicine visits,” says Randie White, MD.

“We really found it surprising the sheer amount of debt that our urology trainees are carrying,” Harris said.

“I think the take home message is that when you're interviewing applicants in your program, take a step back and think about the questions you want to ask,” says Stephanie J. Kielb, MD.

Hamilton discusses findings from a recent study published in European Urology.

The study encompassed the prostatic urethral lift (UroLift), water vapor thermal therapy (Rezum), and temporary implantable nitinol device (iTIND).